Full Text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Supplementation is crucial for improving performance and health in phenylketonuria (PKU) patients, who face dietary challenges. Proteins are vital for athletes, supporting muscle growth, minimizing catabolism, and aiding muscle repair and glycogen replenishment post-exercise. However, PKU individuals must limit phenylalanine (Phe) intake, requiring supplementation with Phe-free amino acids or glycomacropeptides. Tailored to meet nutritional needs, these substitutes lack Phe but fulfill protein requirements. Due to limited supplement availability, athletes with PKU may need higher protein intake. Various factors affect tolerated Phe levels, including supplement quantity and age. Adhering to supplement regimens optimizes performance and addresses PKU challenges. Strategically-timed protein substitutes can safely enhance muscle synthesis and sports performance. Individualized intake is essential for optimal outcomes, recognizing proteins’ multifaceted role. Here, we explore protein substitute supplementation in PKU patients within the context of physical activity, considering limited evidence.

Details

Title
Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence
Author
González-Lamuño, Domingo 1   VIAFID ORCID Logo  ; Morencos, Carmenmelina 2 ; Arrieta, Francisco J 3   VIAFID ORCID Logo  ; Venegas, Eva 4 ; Vicente-Rodríguez, Germán 5   VIAFID ORCID Logo  ; Casajús, José Antonio 5   VIAFID ORCID Logo  ; Maria Luz Couce 6   VIAFID ORCID Logo  ; Aldámiz-Echevarría, Luís 7 

 University Hospital “Marqués de Valdecilla”, Universidad de Cantabria and Research Institute Valdecilla (IDIVAL), 39008 Santander, Spain; Exercise and Health in Special Population Spanish Research Net (EXERNET), 50009 Zaragoza, Spain; [email protected] (G.V.-R.); [email protected] (J.A.C.); Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)—AECOM&Sociedad, 28221 Majadahonda, Spain; [email protected] (F.J.A.); [email protected] (E.V.); [email protected] (M.L.C.); [email protected] (L.A.-E.) 
 Danone Nutricia Metabolics, 28043 Madrid, Spain; [email protected] 
 Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)—AECOM&Sociedad, 28221 Majadahonda, Spain; [email protected] (F.J.A.); [email protected] (E.V.); [email protected] (M.L.C.); [email protected] (L.A.-E.); Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain 
 Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)—AECOM&Sociedad, 28221 Majadahonda, Spain; [email protected] (F.J.A.); [email protected] (E.V.); [email protected] (M.L.C.); [email protected] (L.A.-E.); Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla, 41013 Seville, Spain 
 Exercise and Health in Special Population Spanish Research Net (EXERNET), 50009 Zaragoza, Spain; [email protected] (G.V.-R.); [email protected] (J.A.C.); Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain; EXER-GENUD (Growth, Exercise, Nutrition and Development) Research Group, Universidad de Zaragoza, 50009 Zaragoza, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERObn), 28040 Madrid, Spain; Faculty of Health and Sport Sciences, FCSD, Ronda Misericordia 5, 22001 Huesca, Spain 
 Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)—AECOM&Sociedad, 28221 Majadahonda, Spain; [email protected] (F.J.A.); [email protected] (E.V.); [email protected] (M.L.C.); [email protected] (L.A.-E.); Unit for Diagnosis and Treatment of Congenital Metabolic Disorders, University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, 15706 Santiago de Compostela, Spain 
 Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)—AECOM&Sociedad, 28221 Majadahonda, Spain; [email protected] (F.J.A.); [email protected] (E.V.); [email protected] (M.L.C.); [email protected] (L.A.-E.); Instituto de Investigación Sanitaria de Santiago de Compostela, 15706 Santiago de Compostela, Spain 
First page
639
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20726643
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2955877785
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.